213 related articles for article (PubMed ID: 15616152)
1. Metabolism of melatonin by human cytochromes p450.
Ma X; Idle JR; Krausz KW; Gonzalez FJ
Drug Metab Dispos; 2005 Apr; 33(4):489-94. PubMed ID: 15616152
[TBL] [Abstract][Full Text] [Related]
2. Further assessment of 17alpha-ethinyl estradiol as an inhibitor of different human cytochrome P450 forms in vitro.
Chang SY; Chen C; Yang Z; Rodrigues AD
Drug Metab Dispos; 2009 Aug; 37(8):1667-75. PubMed ID: 19454483
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of procarcinogen-bioactivating human CYP1A1, CYP1A2 and CYP1B1 enzymes by melatonin.
Chang TK; Chen J; Yang G; Yeung EY
J Pineal Res; 2010 Jan; 48(1):55-64. PubMed ID: 19919601
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity.
Hanna IH; Dawling S; Roodi N; Guengerich FP; Parl FF
Cancer Res; 2000 Jul; 60(13):3440-4. PubMed ID: 10910054
[TBL] [Abstract][Full Text] [Related]
5. Oxidation of xenobiotics by recombinant human cytochrome P450 1B1.
Shimada T; Gillam EM; Sutter TR; Strickland PT; Guengerich FP; Yamazaki H
Drug Metab Dispos; 1997 May; 25(5):617-22. PubMed ID: 9152602
[TBL] [Abstract][Full Text] [Related]
6. Contribution of individual cytochrome P450 isozymes to the O-demethylation of the psychotropic beta-carboline alkaloids harmaline and harmine.
Yu AM; Idle JR; Krausz KW; Küpfer A; Gonzalez FJ
J Pharmacol Exp Ther; 2003 Apr; 305(1):315-22. PubMed ID: 12649384
[TBL] [Abstract][Full Text] [Related]
7. Oxidative metabolism of the alkaloid rutaecarpine by human cytochrome P450.
Ueng YF; Don MJ; Jan WC; Wang SY; Ho LK; Chen CF
Drug Metab Dispos; 2006 May; 34(5):821-7. PubMed ID: 16501007
[TBL] [Abstract][Full Text] [Related]
8. Identification of cytochrome P450 isoforms involved in 1-hydroxylation of pyrene.
Kim YD; Todoroki H; Oyama T; Isse T; Matsumoto A; Yamaguchi T; Kim H; Uchiyama I; Kawamoto T
Environ Res; 2004 Mar; 94(3):262-6. PubMed ID: 15016593
[TBL] [Abstract][Full Text] [Related]
9. Characterization of human cytochrome p450 enzymes involved in the metabolism of cilostazol.
Hiratsuka M; Hinai Y; Sasaki T; Konno Y; Imagawa K; Ishikawa M; Mizugaki M
Drug Metab Dispos; 2007 Oct; 35(10):1730-2. PubMed ID: 17646278
[TBL] [Abstract][Full Text] [Related]
10. NADPH- and hydroperoxide-supported 17beta-estradiol hydroxylation catalyzed by a variant form (432L, 453S) of human cytochrome P450 1B1.
Spink DC; Spink BC; Zhuo X; Hussain MM; Gierthy JF; Ding X
J Steroid Biochem Mol Biol; 2000 Sep; 74(1-2):11-8. PubMed ID: 11074351
[TBL] [Abstract][Full Text] [Related]
11. Metabolic activation of dacarbazine by human cytochromes P450: the role of CYP1A1, CYP1A2, and CYP2E1.
Reid JM; Kuffel MJ; Miller JK; Rios R; Ames MM
Clin Cancer Res; 1999 Aug; 5(8):2192-7. PubMed ID: 10473105
[TBL] [Abstract][Full Text] [Related]
12. Human CYP1B1 and anticancer agent metabolism: mechanism for tumor-specific drug inactivation?
Rochat B; Morsman JM; Murray GI; Figg WD; McLeod HL
J Pharmacol Exp Ther; 2001 Feb; 296(2):537-41. PubMed ID: 11160641
[TBL] [Abstract][Full Text] [Related]
13. Identification of human cytochrome P450 isoforms involved in the 3-hydroxylation of quinine by human live microsomes and nine recombinant human cytochromes P450.
Zhao XJ; Yokoyama H; Chiba K; Wanwimolruk S; Ishizaki T
J Pharmacol Exp Ther; 1996 Dec; 279(3):1327-34. PubMed ID: 8968357
[TBL] [Abstract][Full Text] [Related]
14. Differential inhibition and inactivation of human CYP1 enzymes by trans-resveratrol: evidence for mechanism-based inactivation of CYP1A2.
Chang TK; Chen J; Lee WB
J Pharmacol Exp Ther; 2001 Dec; 299(3):874-82. PubMed ID: 11714871
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of CYP1 by berberine, palmatine, and jatrorrhizine: selectivity, kinetic characterization, and molecular modeling.
Lo SN; Chang YP; Tsai KC; Chang CY; Wu TS; Ueng YF
Toxicol Appl Pharmacol; 2013 Nov; 272(3):671-80. PubMed ID: 23886934
[TBL] [Abstract][Full Text] [Related]
16. A metabolomic perspective of melatonin metabolism in the mouse.
Ma X; Chen C; Krausz KW; Idle JR; Gonzalez FJ
Endocrinology; 2008 Apr; 149(4):1869-79. PubMed ID: 18187545
[TBL] [Abstract][Full Text] [Related]
17. 7H-dibenzo[c,g]carbazole metabolism by the mouse and human CYP1 family of enzymes.
Shertzer HG; Genter MB; Talaska G; Curran CP; Nebert DW; Dalton TP
Carcinogenesis; 2007 Jun; 28(6):1371-8. PubMed ID: 17166882
[TBL] [Abstract][Full Text] [Related]
18. Biotransformation of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075), a novel antimicrotubule agent, by mouse, rat, dog, and human liver microsomes.
Yao HT; Wu YS; Chang YW; Hsieh HP; Chen WC; Lan SJ; Chen CT; Chao YS; Chang L; Sun HY; Yeh TK
Drug Metab Dispos; 2007 Jul; 35(7):1042-9. PubMed ID: 17403915
[TBL] [Abstract][Full Text] [Related]
19. Cytochrome P4502C9 is the principal catalyst of racemic acenocoumarol hydroxylation reactions in human liver microsomes.
Thijssen HH; Flinois JP; Beaune PH
Drug Metab Dispos; 2000 Nov; 28(11):1284-90. PubMed ID: 11038154
[TBL] [Abstract][Full Text] [Related]
20. Preference for
Nagayoshi H; Murayama N; Tsujino M; Takenaka S; Katahira J; Kim V; Kim D; Komori M; Yamazaki H; Guengerich FP; Shimada T
Xenobiotica; 2020 Oct; 50(10):1158-1169. PubMed ID: 32312164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]